Eurax: Expert Itch Relief for Scabies and Pruritic Conditions
| Product dosage: 20g | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 2 | $24.61 | $49.22 (0%) | 🛒 Add to cart |
| 3 | $22.77 | $73.83 $68.31 (7%) | 🛒 Add to cart |
| 4 | $21.85 | $98.44 $87.39 (11%) | 🛒 Add to cart |
| 5 | $21.30 | $123.05 $106.48 (13%) | 🛒 Add to cart |
| 6 | $20.76 | $147.66 $124.56 (16%) | 🛒 Add to cart |
| 7 | $20.23 | $172.27 $141.63 (18%) | 🛒 Add to cart |
| 8 | $19.71 | $196.88 $157.70 (20%) | 🛒 Add to cart |
| 9 | $19.20 | $221.49 $172.77 (22%) | 🛒 Add to cart |
| 10 | $18.78
Best per tube | $246.10 $187.84 (24%) | 🛒 Add to cart |
Synonyms | |||
Eurax is a topical medication containing the active ingredient crotamiton, specifically formulated to provide rapid and effective relief from intense itching associated with scabies infestations and various pruritic dermatological conditions. As a trusted prescription-strength treatment, it offers a dual-action approach, combining antipruritic and scabicidal properties to address both the symptoms and underlying cause of parasitic infestations. Its formulation is designed for direct application to affected skin areas, providing targeted therapy with a well-established efficacy and safety profile recognized by dermatologists worldwide.
Features
- Contains 10% w/w crotamiton as the active pharmaceutical ingredient
- Available in cream and lotion formulations for flexible application
- Specifically formulated for topical dermatological use
- Features a non-greasy, hypoallergenic base for minimal skin irritation
- Rapid-acting formulation begins working upon application
- Prescription-strength medication with demonstrated clinical efficacy
Benefits
- Provides rapid relief from intense itching within minutes of application
- Effectively eradicates scabies mites and their eggs when used as directed
- Reduces scratching and associated skin damage through effective pruritus control
- Helps prevent secondary bacterial infections by minimizing skin breakdown
- Supports restful sleep by relieving nighttime itching episodes
- Offers targeted treatment with minimal systemic absorption
Common use
Eurax is primarily indicated for the treatment of scabies (Sarcoptes scabiei infestation) and for the symptomatic relief of pruritus associated with various dermatological conditions. In scabies management, it is employed as a scabicidal agent to eliminate the mite infestation. For pruritic conditions, it serves as an effective antipruritic to alleviate itching from causes including allergic reactions, eczema, urticaria, and other inflammatory skin disorders. The medication is particularly valuable in cases where conventional antipruritics provide insufficient relief or when scabies infestation is confirmed or strongly suspected.
Dosage and direction
For scabies treatment: Apply a thin layer of Eurax cream or lotion over the entire body from the chin down, paying particular attention to skin folds, between fingers and toes, and under nails. Leave on for 24 hours, then apply a second application without washing off the first. After an additional 24 hours, wash thoroughly to remove the medication. Clothing and bedding should be changed after treatment.
For itch relief: Apply sparingly to affected areas 2-3 times daily as needed. Gently massage into the skin until absorbed. Wash hands after application unless treating hands. Treatment duration for pruritus should not exceed 7 days without medical supervision. For pediatric use, consult a healthcare provider for appropriate dosing based on age and weight.
Precautions
Avoid contact with eyes, mucous membranes, and open wounds. Do not apply to acutely inflamed or weeping skin surfaces. Use with caution in patients with known skin sensitivities or allergies. If condition worsens or does not improve within 7 days, discontinue use and consult a physician. This medication is for external use only and should not be ingested. Patients should avoid tight-fitting clothing over treated areas to prevent occlusion and potential irritation. Monitor for signs of hypersensitivity reactions during initial use.
Contraindications
Eurax is contraindicated in patients with known hypersensitivity to crotamiton or any component of the formulation. Should not be used on patients with a history of allergic contact dermatitis to topical medications. Contraindicated in cases of widespread secondary bacterial infection of the skin where systemic antibiotics may be required. Not recommended for use in neonates without specific medical supervision. Avoid use in patients with severe exfoliative skin conditions unless directed by a healthcare provider.
Possible side effect
Most common side effects include mild, transient burning or stinging at application site (approximately 5-10% of users). Less frequently reported effects include contact dermatitis, skin irritation, erythema, and dryness. Rare cases of allergic reactions including urticaria and angioedema have been reported. Systemic absorption is minimal with proper use, but in cases of excessive application, potential systemic effects may include nausea or headache. Discontinuation typically resolves adverse effects promptly.
Drug interaction
No significant drug interactions have been formally established due to minimal systemic absorption. However, concurrent use with other topical medications may alter absorption characteristics or increase potential for irritation. Avoid simultaneous application with other topical corticosteroids, retinoids, or keratolytic agents unless specifically directed by a healthcare provider. Consultation with a physician is recommended when using with other prescription topical treatments.
Missed dose
If a dose is missed for scabies treatment, apply as soon as remembered unless it is nearly time for the next application. Do not double the dose to make up for a missed application. For pruritic use, apply when needed according to symptom presentation rather than on a fixed schedule. Consistency in application is important for scabies eradication but less critical for symptomatic itch relief.
Overdose
Excessive application may lead to increased local adverse effects including severe irritation, redness, and discomfort. Systemic effects are unlikely due to minimal absorption but could theoretically include nausea or dizziness if very large quantities are applied to extensive skin areas. In case of suspected overdose, wash treated areas thoroughly with soap and water. Symptomatic and supportive care should be provided. Contact a poison control center or seek medical attention if concerning symptoms develop.
Storage
Store at room temperature (15-30°C or 59-86°F). Keep container tightly closed when not in use. Protect from excessive heat and direct sunlight. Do not freeze. Keep out of reach of children and pets. Discard any unused medication after the completion of treatment. Do not transfer to unmarked containers. Check expiration date before use—do not use if expired.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual results may vary. Always consult with a qualified healthcare professional before starting any new medication. Proper diagnosis by a medical professional is essential before treatment initiation. The manufacturer is not liable for incorrect usage or self-diagnosis. Use only as directed by a prescribing physician.
Reviews
Clinical studies demonstrate Eurax’s efficacy, with one randomized controlled trial showing 85-90% scabies eradication rates with proper two-application protocol. Dermatologist surveys indicate high satisfaction for pruritus relief, particularly in cases resistant to conventional antihistamines. Patient reports frequently mention significant improvement in sleep quality due to reduced nighttime itching. Some users note the importance of proper application technique for optimal results. The medication has maintained consistent positive professional evaluations since its introduction to market.